← Leaderboards
W D Hager
University Of Connecticut Sch Of Med/Dnt
$23,472
Attributed
$23,472
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$23,472 · 1
By mechanism
M01$23,472 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Peter James Krause$2,079,888
- Karen M Prestwood$365,671
- Nancy M Petry$42,616,169
- Scott Kurtzman$205,028
- Pamela Taxel$261,998
Others in their field
Top investigators on “Beta Antiadrenergic Agent”
- Christopher M O'Connor · Duke University$18,508,673
- Michael A Kass · Washington University$9,081,282
- Bruce M Psaty · University Of Washington$5,047,845
- Kenneth Allen Holroyd · Ohio University Athens$2,665,090
- Jeffrey H Silverstein · Mount Sinai School Of Medicine Of Nyu$2,655,974
- Susan Heckbert · University Of Washington$2,562,214
Research focus
Beta Antiadrenergic AgentBioimaging /Biomedical ImagingClinical ResearchCongestive Heart FailureEchocardiographyGenetic Registry /Resource /Referral CenterHeart Disorder ChemotherapyHuman SubjectHuman Therapy EvaluationOutcomes Research
Grant awards (7)
BETA BLOCKER EVALUATION OF SURVIVAL TRIALS$0
M01 · FY2002 · RR
BETA BLOCKER EVALUATION OF SURVIVAL TRIALS$4,361
M01 · FY2001 · RR
BETA BLOCKER EVALUATION OF SURVIVAL TRIALS$0
M01 · FY2001 · RR
BETA BLOCKER EVALUATION OF SURVIVAL TRIALS$0
M01 · FY2001 · RR
BETA BLOCKER EVALUATION OF SURVIVAL TRIALS$19,111
M01 · FY2000 · RR
BETA BLOCKER EVALUATION OF SURVIVAL TRIALS$0
M01 · FY2000 · RR
BETA BLOCKER EVALUATION OF SURVIVAL TRIALS$0
M01 · FY2000 · RR